Search
Descriptor English: Rivaroxaban
Descriptor Spanish: Rivaroxabán
Descriptor Portuguese: Rivaroxabana
Descriptor French: Rivaroxaban
Entry term(s): 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
BAY 59 7939
BAY 59-7939
BAY 597939
Xarelto
Tree number(s): D02.886.778.727
D03.383.533.640.713
D03.383.903.727
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069552
Scope note: A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Factor Xa Inhibitors
Registry Number: 9NDF7JZ4M3
Public MeSH Note: 2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015
History Note: 2016 (2005)
DeCS ID: 55911
Unique ID: D000069552
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/31
Rivaroxaban - Preferred
Concept UI M0501463
Scope note A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
Preferred term Rivaroxaban
Entry term(s) 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
Xarelto - Narrower
Concept UI M0558836
Preferred term Xarelto
BAY 59-7939 - Narrower
Concept UI M0488536
Preferred term BAY 59-7939
Entry term(s) BAY 59 7939
BAY 597939



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey